Published in BMC Psychiatry on December 27, 2012
A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls. World Psychiatry (2013) 1.03
Metabolic syndrome in schizophrenia. Indian J Psychol Med (2013) 0.92
Prevalence of Metabolic Syndrome in Patients with Schizophrenia Referred to Farabi Hospital, Kermanshah, Iran. Oman Med J (2016) 0.75
The Prevalence of Metabolic Syndrome and Its Related Factors among Adults in Palestine: A Meta-Analysis. Ethiop J Health Sci (2017) 0.75
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med (1998) 46.95
The metabolic syndrome--a new worldwide definition. Lancet (2005) 23.51
Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care (2003) 20.07
Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry (2003) 9.05
Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation (2005) 8.54
Schizophrenia. Lancet (2009) 8.14
Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry (1999) 8.04
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (2009) 7.45
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol (2004) 6.50
A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med (2000) 4.75
Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev (2008) 4.43
Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes (1992) 3.27
Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab (2004) 3.03
Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison. Arch Gen Psychiatry (2001) 2.49
Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry (2007) 2.03
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1. Schizophr Res (2008) 1.95
Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry (2007) 1.94
Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study. Diabetologia (2005) 1.78
Does antipsychotic polypharmacy increase the risk for metabolic syndrome? Schizophr Res (2006) 1.65
Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr Res (2006) 1.64
The metabolic syndrome in the West Bank population: an urban-rural comparison. Diabetes Care (2001) 1.63
Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J Clin Psychiatry (2007) 1.61
Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res (2004) 1.58
Family history of type 2 diabetes in schizophrenic patients. Lancet (1989) 1.54
Comparison of different definitions of the metabolic syndrome. Eur J Clin Invest (2007) 1.52
Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia (2006) 1.48
Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome. Can J Psychiatry (2004) 1.37
Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. Clin Pract Epidemiol Ment Health (2006) 1.33
Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord (2002) 1.31
Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review. Schizophr Res (2008) 1.19
Medical comorbidity in psychiatric inpatients: relation to clinical outcomes and hospital length of stay. Psychosomatics (2002) 1.16
Comparison of metabolic syndrome prevalence using six different definitions in overweight pre-pubertal children enrolled in a weight management study. Int J Obes (Lond) (2006) 1.11
An evaluation of the metabolic syndrome in a large multi-ethnic study: the Family Blood Pressure Program. Nutr Metab (Lond) (2005) 1.09
High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia. Int Clin Psychopharmacol (2006) 1.04
Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study. J Clin Psychiatry (2010) 1.00
Clinical and social correlates with the use of depot antipsychotic drugs in outpatients with schizophrenia in China. Int J Clin Pharmacol Ther (2008) 0.90
Prevalence of metabolic syndrome and associated socioeconomic and demographic factors among Palestinian adults (20-65 years) at the Gaza Strip. Diabetes Metab Syndr (2012) 0.88
Body weight and self-esteem in patients with schizophrenia evaluated with B-WISE. Schizophr Res (2006) 0.87
The metabolic syndrome in the asian population. Curr Hypertens Rep (2005) 0.82
Metabolic syndrome and cardiovascular disease. J Psychopharmacol (2005) 0.81
Mortality in patients with schizophrenia. Lancet (2009) 0.79
Prevention of premature mortality among patients with schizophrenia: the need for primary prevention efforts in cardiovascular disease. CNS Spectr (2008) 0.78
Metabolic syndrome in family practice in Jordan: a study of high-risk groups. East Mediterr Health J (2011) 0.77
Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav (2011) 1.50
Pattern of self-medication with analgesics among Iranian University students in central Iran. J Family Community Med (2012) 1.41
Medical and biomedical research productivity from Palestine, 2002 - 2011. BMC Res Notes (2013) 1.18
Adherence and satisfaction with oral hypoglycemic medications: a pilot study in Palestine. Int J Clin Pharm (2011) 1.12
Influence of patients' disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health (2014) 1.10
Assessing urology and nephrology research activity in Arab countries using ISI web of science bibliometric database. BMC Res Notes (2014) 1.06
Beliefs and practices regarding childhood fever among parents: a cross-sectional study from Palestine. BMC Pediatr (2013) 1.02
Medication dosing errors in hospitalized patients with renal impairment: a study in Palestine. Pharmacoepidemiol Drug Saf (2007) 1.01
Sleep habits and sleep problems among Palestinian students. Child Adolesc Psychiatry Ment Health (2011) 1.00
Prevalence of depression among people with type 2 diabetes mellitus: a cross sectional study in Palestine. BMC Public Health (2014) 1.00
Pharmacy education and practice in West Bank, Palestine. Am J Pharm Educ (2009) 1.00
Knowledge and practices of pesticide use among farm workers in the West Bank, Palestine: safety implications. Environ Health Prev Med (2010) 0.99
Quantity and quality of obesity-related research in Arab countries: assessment and comparative analysis. Health Res Policy Syst (2014) 0.99
Substance use disorders in Arab countries: research activity and bibliometric analysis. Subst Abuse Treat Prev Policy (2014) 0.93
Antipsychotic medication adherence and satisfaction among Palestinian people with schizophrenia. Curr Clin Pharmacol (2012) 0.89
Contribution of Arab countries to breast cancer research: comparison with non-Arab Middle Eastern countries. BMC Womens Health (2015) 0.87
Extent of potential drug interactions among patients receiving anti-hypertensive medications. Saudi Med J (2005) 0.82
Self-therapy practices among university students in Palestine: focus on herbal remedies. Complement Ther Med (2008) 0.82
Evaluate the impact of hospital types on the availability of antidotes for the management of acute toxic exposures and poisonings in Malaysia. Hum Exp Toxicol (2011) 0.81
The epidemiology of stroke in northern palestine: a 1-year, hospital-based study. J Stroke Cerebrovasc Dis (2008) 0.80
Statin use prior to ischemic stroke onset is associated with decreased in-hospital mortality. Fundam Clin Pharmacol (2011) 0.79
Prevalence of reduced renal function among diabetic hypertensive patients. Int J Physiol Pathophysiol Pharmacol (2008) 0.78
Predictors of in-Hospital Mortality after Acute Stroke: Impact of Gender. Int J Clin Exp Med (2009) 0.78
Effect of prestroke use of angiotensin-converting enzyme inhibitors alone versus combination with antiplatelets and statin on ischemic stroke outcome. Clin Neuropharmacol (2011) 0.78
Conformance to schizophrenia treatment guidelines in North West-Bank, Palestine: focus on antipsychotic dosing and polytherapy. BMC Psychiatry (2013) 0.77
Estimation of 10-year probability bone fracture in a selected sample of Palestinian people using fracture risk assessment tool. BMC Musculoskelet Disord (2013) 0.77
Differences in medication adherence, satisfaction and clinical symptoms in schizophrenic outpatients taking different antipsychotic regimens. Curr Drug Saf (2011) 0.77
Availability of decontamination, elimination enhancement, and stabilization resources for the management of acute toxic exposures and poisonings in emergency departments in Malaysia. Intern Emerg Med (2011) 0.77
Patterns of anti-hypertensive therapy in diabetic patients with and without reduced renal function. Saudi J Kidney Dis Transpl (2010) 0.77
Relationship between serum acetaminophen concentration and N-acetylcysteine-induced adverse drug reactions. Basic Clin Pharmacol Toxicol (2010) 0.76
Discharge medications among ischemic stroke survivors. J Stroke Cerebrovasc Dis (2009) 0.76
Associations between prescribing nonsteroidal anti-inflammatory drugs and the potential prescription-related problems in a primary care setting. Int J Clin Pharmacol Ther (2012) 0.75
Predictors of "worsening renal function" in patients hospitalized in internal medicine department. Curr Drug Saf (2009) 0.75
Optimal dosing of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: a cross-sectional study in Palestine. Ann Saudi Med (2009) 0.75
Evaluation of antihypertensive therapy among ischemic stroke survivors: impact of ischemic heart disease. J Cardiovasc Pharmacol Ther (2010) 0.75
Diabetes mellitus in patients with schizophrenia in West-Bank, Palestine. Diabetes Res Clin Pract (2013) 0.75
Impact of angiotensin-converting enzyme inhibitors administration prior to acute ischemic stroke onset on in-hospital mortality. J Cardiovasc Pharmacol Ther (2010) 0.75
Prescribing pattern of angiotensin- converting enzyme inhibitors and beta blockers after acute myocardial infarction. Saudi Med J (2005) 0.75
Impact of the additive effect of angiotensin-converting enzyme inhibitors and /or statins with antiplatelet medication on mortality after acute ischaemic stroke. Basic Clin Pharmacol Toxicol (2011) 0.75
Photodynamic inactivation of trypsin by the aminophylline-riboflavin system: involvement of hydroxyl radical. Med Sci Monit (2006) 0.75